Shares outstanding increased 99.2%
Shares outstanding changed +99.2% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
752,755→1,499,8388 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NDRA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development decreased 38.7%
Research & development changed -38.7% from the comparable as-filed period.
$381,061→$233,6652 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.